These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19496148)

  • 1. A first-in-man study of percutaneous myocardial cryotreatment in nonrevascularizable patients with refractory angina.
    Gallo R; Fefer P; Freeman M; Andrew P; Stewart DJ; Theroux P; Strauss BH
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):387-94. PubMed ID: 19496148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new option for the "no-option" patient with refractory angina?
    Henry TD
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):395-7. PubMed ID: 19681118
    [No Abstract]   [Full Text] [Related]  

  • 3. [Percutaneous myocardial laser revascularization. A new therapy technique for patients with coronary disease and severe angina pectoris without conventional therapy options].
    Lauer B; Stahl F; Junghans U; Kluge R; Schuler G
    Dtsch Med Wochenschr; 2000 Mar; 125(13):377-82. PubMed ID: 10778398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease.
    Lauer B; Junghans U; Stahl F; Kluge R; Oesterle SN; Schuler G
    J Am Coll Cardiol; 1999 Nov; 34(6):1663-70. PubMed ID: 10577553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary autologous CD34+ stem cell therapy for intractable angina.
    Wang S; Cui J; Peng W; Lu M
    Cardiology; 2010; 117(2):140-7. PubMed ID: 20975266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous transmyocardial revascularization with holmium laser in patients with refractory angina: a pilot feasibility study.
    Galli M; Zerboni S; Politi A; Llambro M; Bonatti R; Molteni S; Ferrari G
    G Ital Cardiol; 1999 Sep; 29(9):1020-6. PubMed ID: 10514960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina.
    Allen KB; Dowling RD; Fudge TL; Schoettle GP; Selinger SL; Gangahar DM; Angell WW; Petracek MR; Shaar CJ; O'Neill WW
    N Engl J Med; 1999 Sep; 341(14):1029-36. PubMed ID: 10502592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of transmyocardial laser revascularization and thoracic sympathectomy for the treatment of refractory angina.
    Galiñanes M; Loubani M; Sensky PR; Hassouna A; Cherryman GR; Leverment JN; Samani NJ
    Ann Thorac Surg; 2004 Jul; 78(1):122-8. PubMed ID: 15223416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pacing to reduce refractory angina in patients with severe coronary artery disease: a crossover pilot trial.
    Stolen CM; Lam YM; Siu CW; Lau CP; Parker JA; Hauser TH; Tse HF
    J Cardiovasc Transl Res; 2012 Feb; 5(1):84-91. PubMed ID: 22038623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.
    Losordo DW; Schatz RA; White CJ; Udelson JE; Veereshwarayya V; Durgin M; Poh KK; Weinstein R; Kearney M; Chaudhry M; Burg A; Eaton L; Heyd L; Thorne T; Shturman L; Hoffmeister P; Story K; Zak V; Dowling D; Traverse JH; Olson RE; Flanagan J; Sodano D; Murayama T; Kawamoto A; Kusano KF; Wollins J; Welt F; Shah P; Soukas P; Asahara T; Henry TD
    Circulation; 2007 Jun; 115(25):3165-72. PubMed ID: 17562958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Percutaneous myocardial laser revascularization (PMR), a new therapeutic procedure for patients with refractory angina pectoris].
    Lauer B; Stahl F; Bratanow S; Schuler G
    Z Kardiol; 2000; 89 Suppl 7():31-6. PubMed ID: 11098557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous myocardial laser revascularization in patients with refractory angina pectoris.
    Gray TJ; Burns SM; Clarke SC; Tait S; Sharples LD; Caine N; Schofield PM
    Am J Cardiol; 2003 Mar; 91(6):661-6. PubMed ID: 12633794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina.
    Briguori C; Reimers B; Sarais C; Napodano M; Pascotto P; Azzarello G; Bregni M; Porcellini A; Vinante O; Zanco P; Peschle C; Condorelli G; Colombo A
    Am Heart J; 2006 Mar; 151(3):674-80. PubMed ID: 16504630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial.
    Favaloro L; Diez M; Mendiz O; Janavel GV; Valdivieso L; Ratto R; Garelli G; Salmo F; Criscuolo M; Bercovich A; Crottogini A
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):899-906. PubMed ID: 22777825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease.
    Frazier OH; March RJ; Horvath KA
    N Engl J Med; 1999 Sep; 341(14):1021-8. PubMed ID: 10502591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina: A Single-Center Experience.
    Giannini F; Baldetti L; Ponticelli F; Ruparelia N; Mitomo S; Latib A; Montorfano M; Jabbour RJ; Aurelio A; Ferri L; Mangieri A; Regazzoli D; Ancona M; Pagnesi M; Faccini A; Chieffo A; Azzalini L; Carlino M; Colombo A
    JACC Cardiovasc Interv; 2018 Apr; 11(8):784-792. PubMed ID: 29673511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina.
    Alunni G; Marra S; Meynet I; D'amico M; Elisa P; Fanelli A; Molinaro S; Garrone P; Deberardinis A; Campana M; Lerman A
    Cardiovasc Revasc Med; 2015; 16(1):6-11. PubMed ID: 25555620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina--final 3-year follow-up.
    Mathiasen AB; Haack-Sørensen M; Jørgensen E; Kastrup J
    Int J Cardiol; 2013 Dec; 170(2):246-51. PubMed ID: 24211066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial.
    Jolicœur EM; Banai S; Henry TD; Schwartz M; Doucet S; White CJ; Edelman E; Verheye S
    Trials; 2013 Feb; 14():46. PubMed ID: 23413981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images.
    Venkataraman R; Belardinelli L; Blackburn B; Heo J; Iskandrian AE
    JACC Cardiovasc Imaging; 2009 Nov; 2(11):1301-9. PubMed ID: 19909934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.